HonCode

Go Back   HER2 Support Group Forums > Breast Cancer Newsfeed
Reload this Page Celsion To Report Clinical Trial Update Of ThermoDox(R) In Recurrent Chest Wall Breas
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 02-24-2009, 11:10 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,958
Celsion To Report Clinical Trial Update Of ThermoDox(R) In Recurrent Chest Wall Breas
Celsion Corporation (NASDAQ: CLSN) today announced that clinical data from its ThermoDox® Phase 1 Recurrent Chest Wall (RCW) Breast Cancer study will be presented by Duke University Medical Center researchers at the Society for Thermal Medicine 2009 Annual Meeting in Tucson, Arizona on April 3-7, 2009.

More...
News is offline   Reply With Quote
Old 02-24-2009, 02:20 PM   #2
Rich66
Senior Member
 
Rich66's Avatar
 
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
"ThermoDox® has also demonstrated remarkable evidence of efficacy in a Phase 1 study for primary liver cancer. "

I wonder if this might translate into efficacy with BC mets to the liver.
Rich66 is offline   Reply With Quote
Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -7. The time now is 04:10 PM.
Contact Us - HER2 Support Group - Archive - Privacy Statement - Top

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter